Value of the DST for predicting response of patients with major depression to hospitalization and desipramine.
The authors examined the value of the dexamethasone suppression test (DST) for predicting response of patients with unipolar, nonpsychotic major depression to 1 week of hospitalization without antidepressant drugs and to a 4-week trial of desipramine at a fixed plasma level. The rates of response to hospitalization without drug treatment (defined as a score of 12 or less on the Hamilton Rating Scale for Depression) were not significantly different for the patients with a positive DST and those with a negative DST. This finding differs from those of prior studies of the DST and response to placebo. The responses of the DST-positive and DST-negative patients to desipramine also did not differ, a finding that replicates those in some prior reports.
Nelson
J C
JC
Department of Psychiatry, Yale University School of Medicine, New Haven, CT 06510.
Mazure
C M
CM
Jatlow
P I
PI
D000328:Adult; D003866:Depressive Disorder / Q000175:diagnosis / Q000188:drug therapy / Q000628:therapy*; D003891:Desipramine / Q000627:therapeutic use*; D003907:Dexamethasone; D005260:Female; D006760:Hospitalization; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D008297:Male; D011336:Probability; D011569:Psychiatric Status Rating Scales
D003907:Dexamethasone; D003891:Desipramine; D006854:Hydrocortisone